Related Experiment Video
Updated: Mar 23, 2026
13:36
Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
Published on: May 6, 2015
10.8K
An Adenoviral Vector Based Vaccine for Rhodococcus equi
Carla Giles1, Olasumbo Ndi1, Mary D Barton1
1School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, South Australia, Australia.
Plos One
|March 24, 2016
Summary
A novel vaccine for Rhodococcus equi, a deadly foal respiratory pathogen, shows promise. Tested in mice, the adenoviral vector vaccine generated strong immune responses and cleared the bacteria, offering hope for foal health.
Area of Science:
- Veterinary Medicine
- Immunology
- Microbiology
Background:
- Rhodococcus equi causes severe respiratory disease in foals, with high mortality and morbidity rates.
- Existing treatments are limited, and no effective vaccine is currently available for Rhodococcus equi infections.
- The endemic nature of this pathogen on farms worldwide necessitates novel prevention strategies.
Purpose of the Study:
- To develop and evaluate a novel vaccine candidate for Rhodococcus equi using a human adenoviral vector.
- To assess the immunogenicity and efficacy of the novel vaccine in a preclinical mouse model.
Main Methods:
- Development of a human adenoviral vector vaccine targeting Rhodococcus equi.
- Immunization of mice with the novel vaccine.
- Assessment of antibody and cytokine responses post-vaccination.
- Bacterial challenge with Rhodococcus equi and evaluation of bacterial clearance.
Main Results:
- The novel adenoviral vector vaccine successfully induced a robust antibody response in the mouse model.
- Significant cytokine production was observed, indicating a strong cellular immune response.
- Vaccinated mice demonstrated clearance of Rhodococcus equi following challenge, suggesting vaccine efficacy.
Conclusions:
- The developed human adenoviral vector vaccine is immunogenic and protective against Rhodococcus equi challenge in a mouse model.
- These findings support further development of this vaccine for potential use in preventing Rhodococcus equi disease in foals.
- This novel vaccine represents a potential breakthrough in combating a significant threat to equine health.
